| Ms Elisabeth Noel Walker, CRNA | |
|
200 W Arbor Dr Mc 8201, Ucsd Medical Center, San Diego, CA 92103-8201 | |
| (619) 543-5720 | |
| (619) 543-3183 |
| Full Name | Ms Elisabeth Noel Walker |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 200 W Arbor Dr Mc 8201, San Diego, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003864984 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | CRNA2578 (California) | Primary |
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265535702 PECOS PAC ID: 3577476761 Enrollment ID: O20040102000635 |
News Archive
Scientists at Columbia University's Mailman School of Public Health, the South African National Institute for Communicable Diseases of National Health Laboratory Service (NICD-NHLS), the U.S. Centers for Disease Control and Prevention, and Roche's 454 Life Sciences Corporation have discovered the new virus responsible for a highly fatal hemorrhagic fever outbreak in Zambia and South Africa in late 2008.
New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.
The focus of the Uniting to Combat Neglected Tropical Diseases: Translating the London Declaration into Action conference, which took place November 16-18 in Washington, D.C., was "how we can work together to put the right systems in place and implement the change needed" to control or eliminate neglected tropical diseases (NTDs) by 2020, Simon Bush, director of NTDs at Sightsavers, writes in the Huffington Post U.K.'s "Impact" blog.
Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Elisabeth Noel Walker, CRNA Po Box 232410, San Diego, CA 92193-2410 Ph: (858) 249-6748 | Ms Elisabeth Noel Walker, CRNA 200 W Arbor Dr Mc 8201, Ucsd Medical Center, San Diego, CA 92103-8201 Ph: (619) 543-5720 |
News Archive
Scientists at Columbia University's Mailman School of Public Health, the South African National Institute for Communicable Diseases of National Health Laboratory Service (NICD-NHLS), the U.S. Centers for Disease Control and Prevention, and Roche's 454 Life Sciences Corporation have discovered the new virus responsible for a highly fatal hemorrhagic fever outbreak in Zambia and South Africa in late 2008.
New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.
The focus of the Uniting to Combat Neglected Tropical Diseases: Translating the London Declaration into Action conference, which took place November 16-18 in Washington, D.C., was "how we can work together to put the right systems in place and implement the change needed" to control or eliminate neglected tropical diseases (NTDs) by 2020, Simon Bush, director of NTDs at Sightsavers, writes in the Huffington Post U.K.'s "Impact" blog.
Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.
› Verified 5 days ago
Ardis L Taschner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 619-528-5000 | |
Lena Grace Stephens, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 34800 Bob Wilson Dr, San Diego, CA 92134 Phone: 619-532-8943 | |
Heidemarie Dreger, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4405 Vandever Ave, San Diego, CA 92120 Phone: 619-528-5000 | |
Mr. Jason Wyatt Cole, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 | |
Mrs. Maryanne Elizabeth Baumgartner, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 34800 Bob Wilson Dr, San Diego, CA 92134 Phone: 619-532-8960 | |
Mr. Ryan L Nations, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 Fax: 888-539-8781 |